Fluidigm Reports Strong Q2 2013 Revenue Growth Of 35%
Record Instrument Revenue Driven by Rapidly Growing Single-Cell Genomics Market

Fluidigm Enables the Study of miRNA Master Regulators Down to the Single Cell Level
C1TM System Provides Simplest, Most Sensitive Method to Investigate Gene Regulation

Fluidigm and Olink Bioscience Bring a New Level of Protein Biomarker Discovery to the Market

Fluidigm to Announce Q2 2013 Financial Results and Host Conference Call for Investors

Rapid Detection of Pathogens Will Help Control Threats such as Flu Pandemic and SARS
Rapid Detection of Pathogens by the Fluidigm System Will Help Control Serious Threats to Public Health such as Flu Pandemics and SARS.

Fluidigm to Present at the Bank Of America Merrill Lynch 2013 Health Care Conference

Revenue Up 33% and Margins Increase 300 Basis Points Compared to Q1 2012

Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing
Custom system will ultimately enable DKMS Life Science Lab to type several thousand samples per week

For Immediate Release
Fluidigm to Announce Q1 2013 Financial Results and Host Conference Call for Investors

Centre Dedicated to Diagnosis and Treatment Derived from Single-Cell Exploration
Singapore Single-Cell Research Centre Opens Door For Asian Biological Discoveries